Multiple Sclerosis
![Marché sclérose en plaques](https://mabdesign.fr/wp-content/uploads/2024/08/Multiple-Sclerosis-September-768x1024.png)
This month’s MabDesign market analysis gives you an overview of market dynamics and development projects targeting the treatment of multiple sclerosis.
The immuno-oncology market
![marché immuno-oncologie](https://mabdesign.fr/wp-content/uploads/2024/08/shutterstock_1476281402-1024x576.jpg)
Long considered as cellular debris with no biological function, exosomes, and more generally extracellular vesicles (EVs), are now recognized as vectors of biological material with a role in intercellular communication. The building of knowledge on the subject has not only highlighted their role in certain pathologies, but also revealed their potential as biomarkers and therapeutic tools.
Glioblastoma
![marché glioblastome](https://mabdesign.fr/wp-content/uploads/2024/07/Glioblastoma-July-768x1024.png)
This month’s MabDesign market analysis gives you an overview of market dynamics and pipeline projects targeting the glioblastoma.
Cell and gene therapies
![thérapie cellulaire, thérapie génique, marché, pipeline, ICGT](https://mabdesign.fr/wp-content/uploads/2024/04/MabDesign-Market-analysis-CellGene-therapies-April-2024--724x1024.png)
The first edition of our Innovations for Cell and Gene Therapies (ICGT) congress, organized in collaboration with the Société Française de Thérapie Cellulaire et génique (SFTCG), will take place on May 22, 2024, in Paris. In the meantime, this month we share an overview of the cell and gene therapy market.